What is FOXO BioScience?
FOXO BioScience is at the forefront of epigenetic testing, offering advanced services and technology designed to accelerate groundbreaking scientific discoveries. The company's innovative solutions cater to the research community and the rapidly expanding longevity sector, providing critical insights for disruptive business initiatives and advancements in healthspan.
How much funding has FOXO BioScience raised?
FOXO BioScience has raised a total of $10M across 1 funding round:
Private Equity
$10M
Private Equity (2021): $10M with participation from Bespoke Growth Partners
Key Investors in FOXO BioScience
Bespoke Growth Partners
Bespoke Growth Partners is an investment firm that likely focuses on providing strategic capital and operational expertise to companies within the life sciences and technology sectors, aiming to foster significant growth and market penetration.
What's next for FOXO BioScience?
The recent major strategic investment signals a new phase of growth and development for FOXO BioScience. This capital infusion is expected to fuel further expansion of its epigenetic testing platforms, enhance its technological capabilities, and broaden its market reach within the longevity industry. The company is poised to leverage this strategic backing to solidify its leadership in translating epigenetic insights into tangible commercial applications and scientific breakthroughs.
See full FOXO BioScience company page
